PUBLISHER: The Business Research Company | PRODUCT CODE: 1942650
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942650
Demineralized bone fiber technology involves treating human or animal bone to remove minerals while preserving the collagen matrix, creating a flexible bone graft material. This technology is mainly used in orthopedic and dental surgeries to support bone healing and regeneration. Its osteoinductive properties aid in stimulating new bone growth at the implantation site.
The primary product types in demineralized bone fiber technology are allograft, demineralized bone matrix (DBM), synthetic, and xenograft. Allografts are bone grafts obtained from a donor, typically a deceased individual, used in surgeries to repair or replace damaged bones. The materials used include collagen, hydroxyapatite, polymers, and tricalcium phosphate. Applications are concentrated in dental procedures, joint reconstruction, spinal fusion, and trauma care. End-users of these products include ambulatory surgical centers, hospitals, and specialty clinics.
Tariffs are impacting the demineralized bone fiber technology market by increasing costs associated with imported raw bone materials, biologic processing equipment, and sterilization inputs. These effects are most evident across allograft and DBM product segments, particularly in regions reliant on international tissue sourcing such as North America and Europe. Higher tariffs have influenced pricing and procurement cycles for hospitals and specialty clinics. At the same time, tariffs are encouraging localized tissue processing and domestic manufacturing, supporting supply chain security and long-term regional production growth.
The demineralized bone fiber technology market research report is one of a series of new reports from The Business Research Company that provides demineralized bone fiber technology market statistics, including demineralized bone fiber technology industry global market size, regional shares, competitors with a demineralized bone fiber technology market share, detailed demineralized bone fiber technology market segments, market trends and opportunities, and any further data you may need to thrive in the demineralized bone fiber technology industry. This demineralized bone fiber technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The demineralized bone fiber technology market size has grown strongly in recent years. It will grow from $1.43 billion in 2025 to $1.53 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to growth in orthopedic surgical procedures, rising incidence of traumatic bone injuries, increasing dental implant procedures, improved clinical acceptance of allografts, expansion of hospital-based orthopedic departments.
The demineralized bone fiber technology market size is expected to see strong growth in the next few years. It will grow to $1.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing aging population, rising demand for minimally invasive bone repair, growth in spinal fusion surgeries, expanding dental restoration procedures, rising preference for biologic graft alternatives. Major trends in the forecast period include rising adoption of osteoinductive bone graft materials, growing use in spinal fusion procedures, increasing preference for flexible bone graft formats, expansion of dental bone regeneration applications, rising demand for off-the-shelf grafting solutions.
The growing incidence of orthopedic disorders is anticipated to drive the expansion of the demineralized bone fiber technology market. Orthopedic disorders, affecting bones, joints, muscles, and surrounding tissues, can impair movement and function. The rising prevalence of these disorders is influenced by factors such as an aging population, sedentary lifestyles, and increasing obesity rates, which contribute to higher rates of joint and bone-related issues. Demineralized bone fiber technology supports bone regeneration in patients with orthopedic disorders by offering a natural scaffold that promotes new bone growth. For example, in January 2024, according to the Office for Health Improvement and Disparities, a UK-based government agency, the prevalence of self-reported long-term musculoskeletal (MSK) conditions among individuals aged 16 and over reached 18.4% in 2023, up from 17.6% in 2022. This increasing prevalence of orthopedic disorders is expected to drive growth in the demineralized bone fiber technology market.
Key players in the demineralized bone fiber technology market are developing innovative solutions, such as proprietary demineralized cortical bone fiber technology, to advance medical and dental applications. This technology involves a specialized processing method that removes mineral content from cortical bone, resulting in bone fibers with enhanced biological and mechanical properties. For instance, in February 2024, Tetrous Inc., a US-based regenerative medicine company, introduced the EnFix TAC, a demineralized bone allograft implant designed to improve healing at the enthesis, the junction between bone and tendon, following rotator cuff surgery. Utilizing advanced demineralized bone fiber technology, the EnFix TAC enhances the integration and regeneration of bone and tendon tissues, addressing the issue of scar tissue formation that can impede proper healing. The device provides a supportive framework that facilitates efficient bone-to-tendon integration and accommodates various suture anchor systems, thus optimizing surgical outcomes.
In March 2025, MTF Biologics, a US-based non-profit organization, partnered with Kolosis BIO LLC to advance next-generation biologic solutions in regenerative medicine. The collaboration aims to expand access to and distribution of high-quality demineralized bone matrix (DBM) allograft products, including the DBX brand, improving patient outcomes in orthopedic surgeries while supporting innovation and growth in the biologics market. Kolosis BIO LLC is a biotechnology company focused on the commercialization of advanced biologics for surgical applications.
Major companies operating in the demineralized bone fiber technology market are Johnson & Johnson, Medtronic Plc, Stryker Corporation, Zimmer Biomet, Arthrex Inc., Globus Medical Inc., Integra LifeSciences Corporation, NuVasive Inc., Wright Medical Group N.V., Bioventus LLC, Alphatec Holdings Inc., MTF Biologics, RTI Surgical Holdings Inc., LifeNet Health, SeaSpine Holdings Corporation, AlloSource, Xtant Medical Holdings Inc., Orthofix Medical Inc., Kuros Biosciences AG, Spine Wave Inc., Orthogen LLC
North America was the largest region in the demineralized bone fiber technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the demineralized bone fiber technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the demineralized bone fiber technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The demineralized bone fiber technology market consists of revenues earned by entities providing services such as orthopedic repairs, customized solutions, and bone regeneration. The market value includes the value of related goods sold by the service provider or included within the service offering. The demineralized bone fiber technology market also includes sales of demineralized bone fiber scaffolds, demineralized bone fiber paste, and demineralized bone fiber grafts. manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Demineralized Bone Fiber Technology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses demineralized bone fiber technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for demineralized bone fiber technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The demineralized bone fiber technology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.